Inlyta

Indicated For

advanced renal cell carcinoma, RCC

About This Medication

# Pfizer Patient Assistance Program Patient Guide: How to Get Inlyta (axitinib) at Low or No Cost Inlyta (axitinib) is a prescription medication used to treat advanced renal cell carcinoma (kidney cancer) in adults, often after other treatments have been tried. The **Pfizer Patient Assistance Program (PAP)** provides **Inlyta at no cost** to eligible patients who meet income, insurance, and residency requirements, helping those who cannot afford their medication. ## About Inlyta (axitinib) **Inlyta** is an oral tablet taken twice daily, targeting proteins that help cancer cells grow. It's typically prescribed for patients with advanced kidney cancer when immunotherapy or other therapies aren't suitable. Common side effects include diarrhea, high blood pressure, fatigue, and decreased appetite—always discuss with your doctor. This program covers the full cost for qualifying patients, but it's not a substitute for medical advice. ## Who Qualifies for the Program? Eligibility focuses on three main areas: **income**, **insurance status**, and **residency**. You must: - Reside in the U.S. or a U.S. territory with a valid U.S. address (proof of citizenship not required). - Have a valid prescription from a U.S.-licensed healthcare provider for outpatient use. - Be 18 years or older. - Meet income limits, generally up to **500% of the Federal Poverty Level (FPL)**, though exact household size thresholds vary and are assessed individually. - Have an FDA-approved diagnosis. **Commercially insured patients** (e.g., employer or marketplace plans) are **not eligible** for free medication through this PAP but may qualify for Pfizer's co-pay assistance programs. ## Income Eligibility Breakdown Specific dollar thresholds aren't publicly listed and depend on household size, but sources indicate eligibility up to **500% FPL**. Use the table below for 2026 estimates (FPL updates annually; confirm current levels at application). Provide proof like tax returns, W-2s, or pay stubs. | Household Size | 100% FPL | 500% FPL (Approx. Max for Eligibility) | |---------------|----------|---------------------------------------| | 1 | $15,060 | $75,300 | | 2 | $20,440 | $102,200 | | 3 | $25,820 | $129,100 | | 4 | $31,200 | $156,000 | | +1 person | +$5,380 | +$26,900 | *Notes: Pre-tax household income. Electronic verification optional; manual proof required if opted out. Thresholds subject to change.* ## Insurance Requirements - **Uninsured** patients are prime candidates. - **Government-insured** (Medicare, Medicaid) may qualify if they can't afford costs, but Medicare Part D patients must enroll in the **Medicare Prescription Payment Plan** first and provide documentation. Exhaust other resources if required. - **Denied coverage** by insurer (after appeal) may qualify. - **No commercial insurance**—use Pfizer Oncology Together co-pay cards instead (up to $25,000 annual savings). Prior authorization from your insurer (if needed) must be completed before applying. ## Step-by-Step Application Process 1. **Check Eligibility**: Visit **www.PfizerRxPathways.com**, use the Program Finder, enter "Inlyta", and follow prompts. 2. **Gather Documents**: - Completed enrollment form (patient and doctor sections). - **Proof of income**: 1040 tax return (pages 1-2), W-2, two pay stubs, SSA-1099. - **Proof of residency**: Utility bill, lease. - **Prescription** from U.S.-licensed provider. - **Proof of insurance status**: Cards (front/back), denial letter, Medicare Payment Plan enrollment. 3. **Apply Online (Preferred)**: Use **Pfizer PAP Connect** at pfizerpapconnect.com to complete form, upload docs, track status. New or enrolled patients can register with email/name/ID. 4. **Manual Option**: Download form from PfizerRxPathways, have doctor complete, mail to P.O. Box 66585, St. Louis, MO 63166-6585, or fax 866-470-1748/1-877-548-1734 with cover sheet. 5. **Sign Certifications**: Attest inability to afford meds, authorize income verification. 6. **Submit**: Doctor may fax; retain HIPAA form. ## Timeline and Delivery - **Processing**: 2-3 weeks for enrollment decision notification. - **If Approved**: Receive letter with term (often 1 year), medication **shipped free to your home**. - **Reauthorization**: Required annually or as specified—reauth via PAP Connect or new form. ## Alternatives if Denied or Ineligible - **Co-pay Programs**: Pfizer Oncology Together (1-877-744-5675) for commercial/Medicare insured. - **State Programs**: Apply to Medicaid, state exchanges first if uninsured. - **Other PAPs**: NeedyMeds.org or RxAssist.org for alternatives. - **Manufacturer Contact**: Call Pfizer RxPathways for guidance. - **Biosimilars**: None available for Inlyta. ## Important Disclaimer This guide is for informational purposes based on publicly available data as of 2026. Eligibility rules change; always verify at PfizerRxPathways.com. Not medical/financial advice—consult your doctor. Pfizer or Foundation may deny/terminate anytime. Free meds via Pfizer Patient Assistance Foundation (separate entity). Word count: 1028.

Program information last verified: March 30, 2026